Clinical trials
Active, not recruiting Phase 2/3 trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 12 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Hoffmann-La Roche | 3 |
| NRG Oncology | 3 |
| Gilead Sciences | 2 |
| Janssen Research & Development, LLC | 2 |
| National Cancer Institute (NCI) | 2 |
| Regeneron Pharmaceuticals | 2 |
| University Health Network, Toronto | 2 |
| Washington University School of Medicine | 2 |
| Agios Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 3 |
| Alzheimer Disease | 2 |
| Amyotrophic Lateral Sclerosis | 2 |
| Dementia | 2 |
| Lung Neoplasms | 2 |
| Melanoma | 2 |
| Mucopolysaccharidosis II | 2 |
| Myelodysplastic Syndromes | 2 |
| Neoplasm Metastasis | 2 |
| Pancreatic Neoplasms | 2 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.